Target intelligence / Profile preview

Class A TEM-type beta-lactamase (TEM beta-lactamase)

Target
TEM beta-lactamase
Molecular classification
Enzyme, Hydrolase, Serine beta-lactamase, Class A beta-lactamase, Antibiotic resistance protein
01

Overview

Class A TEM-type beta-lactamase is an enzyme produced by Gram-negative bacteria that confers resistance to beta-lactam antibiotics such as penicillins and early cephalosporins by hydrolyzing the beta-lactam ring, rendering these drugs ineffective[1][3][5]. TEM-1 is the most widespread of these enzymes, plasmid-borne, and highly prevalent in Enterobacteriaceae[3][4]. The catalytic mechanism involves a serine residue at the active site, utilizing a two-step acylation–deacylation process to cleave the antibiotic[1][2][3]. Variants of TEM-type beta-lactamases have adapted to hydrolyze extended-spectrum cephalosporins and resist inhibition by traditional beta-lactamase inhibitors, posing a major clinical challenge in managing infections[1][3][4]. The spread of these enzymes is a leading cause of resistance to commonly used antimicrobials, emphasizing the need for surveillance and novel inhibitors.

Other names
TEM-1 beta-lactamaseTEM-type beta-lactamaseClass A beta-lactamase (TEM family)Beta-lactamase TEM
02

Mechanism of action

Enzymatic hydrolysis of the beta-lactam ring of antibiotics, destroying their antibacterial activity[1][2][3][5] - Resistance to beta-lactamase inhibitors in some TEM variants[1]

03

Biological functions

Hydrolysis of beta-lactam antibioticsAntibiotic resistance mechanismBreakdown of penicillins and cephalosporinsBacterial defense against beta-lactam drugs
04

Disease associations

Infection (mainly bacterial infections resistant to beta-lactam antibiotics)Antimicrobial resistanceOther (spread of resistance plasmids in healthcare settings)
05

Safety considerations

Rapid spread of TEM genes via plasmids among bacterial pathogens[4][5]Development of extended-spectrum and inhibitor-resistant variants[1][3]Limited efficacy of older beta-lactam antibiotics in TEM-producing strainsNeed for accurate diagnostics to prevent treatment failure
06

Interacting drugs

Penicillins (e.g., ampicillin, penicillin G)

3 more in the full profile.

07

Biomarkers

Detection of TEM-type beta-lactamase gene (bla_TEM)Phenotypic resistance to penicillins and early cephalosporinsExtended-spectrum beta-lactamase (ESBL) phenotype in some variants

Beyond the preview

Go deeper on Class A TEM-type beta-lactamase (TEM beta-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class A TEM-type beta-lactamase (TEM beta-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call